Medicenna Therapeutics Corp. - COM (MDNAF)

CUSIP: 58490H107

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
8,281,040
Share change
-336,825
Total reported value
$2,409,139
Price per share
$0.29
Number of holders
25
Value change
-$231,755
Number of buys
7
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Medicenna Therapeutics Corp. - COM (MDNAF) as of Q3 2023

As of 30 Sep 2023, Medicenna Therapeutics Corp. - COM (MDNAF) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,281,040 shares. The largest 10 holders included AIGH Capital Management LLC, Worth Venture Partners, LLC, Hudson Bay Capital Management LP, Sigma Planning Corp, Verition Fund Management LLC, Royal Bank of Canada, LETKO, BROSSEAU & ASSOCIATES INC, Rathbones Group PLC, RENAISSANCE TECHNOLOGIES LLC, and McKinley Carter Wealth Services, Inc.. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.